25CN-NBOMe

From Wikipedia, the free encyclopedia
Jump to: navigation, search
25CN-NBOMe
25CN-NBOMe.svg
Systematic (IUPAC) name
2,5-Dimethoxy-4-(2-(2-methoxybenzylamino)ethyl)benzonitrile
Clinical data
Legal status ?
Identifiers
CAS number 1354632-16-8
ATC code ?
Chemical data
Formula C19H22N2O3 
Mol. mass 326.39 g/mol

25CN-NBOMe (2C-CN-NBOMe, NBOMe-2C-CN) is a derivative of the phenethylamine 2C-CN. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5HT2A receptor.[1][2] 25CN-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

See also[edit]

References[edit]

  1. ^ Hansen, M.; Phonekeo, K.; Paine, J. S.; Leth-Petersen, S.; Begtrup, M.; Bräuner-Osborne, H.; Kristensen, J. L. (2014). "Synthesis and Structure-Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists". ACS Chemical Neuroscience: 140107104401000. doi:10.1021/cn400216u.  edit
  2. ^ Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.